Reckitt Benckiser profits up by 4%
Rakesh Kapoor, its chief executive, said the firm was on track to hit savings of £150m over three years
Nurofen owner Reckitt Benckiser defied the gloom among many consumer goods firms as it posted strong full-year profits yesterday.
The Cillit Bang to Vanish group said like-for-like sales rose by 6 per cent in the year to the end of December, pushing pre-tax profits up 4 per cent to £2.2bn compared with a year ago.
Reckitt Benckiser said its expansion was driven by a strong flu season at the beginning of the year, and by “outstanding” sales from key brands such as Scholl, Durex and Strepsils. It also benefited from strong performances in India and China. Its shares rose 405p, or 7 per cent, to 6,371p.
Rakesh Kapoor, its chief executive, said the firm was on track to hit savings of £150m over three years.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies